1-4 of 4
Jairo Baquero Buitrago
Close
Sort by
Journal Articles

Validation of a Novel Bioluminescent Mouse Model of Sezary Syndrome for Preclinical Drug Screening

Salvia Jain, MD, Luigi Scotto, Ph.D., Enrica Marchi, MD, Ph.D., Matko Kalac, MD, Ph.D., Jennifer Amengual, M.D., Jairo Baquero Buitrago, Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2725.
https://doi.org/10.1182/blood.V118.21.2725.2725
Published: 2011
Journal Articles

Hodgkin's Lymphoma Cell Lines Have up-Regulated IL-3 Receptor α (IL-3Rα) Expression and Are Sensitive to SL-401, An IL-3Rα Targeted Drug,

Catherine S. Diefenbach, MD, Rachel Sabado, PhD, Christopher L. Brooks, PhD, Jairo Baquero-Buitrago, MSc, Crystal Cruz, Isabelita Vengco, Francesca Montanari, MD, Enrica Marchi, MD, Ph.D., Luigi Scotto, Ph.D., Thomas P. Cirrito, PhD, Ivan Bergstein, MD, Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3737.
https://doi.org/10.1182/blood.V118.21.3737.3737
Published: 2011
Journal Articles

Therapeutic Targeting of the Bcl-6: p53 Axis with Histone Deacetylase Inhibitors in Diffuse Large B-Cell Lymphoma,

Jennifer E Amengual, MD, Matko Kalac, MD, Ph.D., Luigi Scotto, Ph.D., Patrick A Sleckman, Enrica Marchi, MD, Ph.D., Changchun Deng, MD, PhD, Danielle C Bongero, Salvia Jain, MD, Jairo Baquero Buitrago, Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3733.
https://doi.org/10.1182/blood.V118.21.3733.3733
Published: 2011
Journal Articles

Generation and Characterization of a Novel CD19-CherryLuciferase (CD19CL) Mouse Model: A New Fluorescent/Bioluminescent Model for the Study of B-Cell Development and Lymphomagenesis

Luigi Scotto, Ph.D., Marianna Kruithof de Julio, Ph.D., Luca Paoluzzi, MD, Matko Kalac, MD, Ph.D., Enrica Marchi, MD, Ph.D., Jairo Baquero Buitrago, BS, Owen A. O'Connor, MD, Ph.D.
Journal: Blood
Blood (2010) 116 (21): 3940.
https://doi.org/10.1182/blood.V116.21.3940.3940
Published: 2010